Patten Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-50
Closed -$3K 327
2018
Q4
$3K Buy
+50
New +$3.5K ﹤0.01% 509
2018
Q3
Sell
-130
Closed -$9K 689
2018
Q2
$9K Sell
130
-200
-61% -$14.1K ﹤0.01% 496
2018
Q1
$25K Hold
330
0.01% 384
2017
Q4
$24K Sell
330
-210
-39% -$15.9K 0.01% 414
2017
Q3
$44K Hold
540
0.02% 339
2017
Q2
$40K Sell
540
-33
-6% -$2.2K 0.02% 343
2017
Q1
$38K Sell
573
-367
-39% -$25.8K 0.02% 335
2016
Q4
$67K Sell
940
-220
-19% -$16.4K 0.03% 278
2016
Q3
$84.7K Sell
1,160
-1,110
-49% -$90.2K 0.04% 257
2016
Q2
$189K Sell
2,270
-915
-29% -$81.2K 0.09% 174
2016
Q1
$293K Sell
3,185
-320
-9% -$28.9K 0.14% 140
2015
Q4
$355K Sell
3,505
-470
-12% -$48.9K 0.17% 125
2015
Q3
$390K Buy
3,975
+510
+15% +$56.6K 0.2% 110
2015
Q2
$406K Buy
3,465
+965
+39% +$105K 0.19% 114
2015
Q1
$245K Hold
2,500
0.13% 154
2014
Q4
$236K Buy
+2,500
New +$259K 0.11% 158

Other funds holding GILD

Patten Group's GILD Position: Q1 2019 in Review

Patten Group sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 50 shares — an estimated $3K sold.

Patten Group first reported a position in GILD in Q4 2014 and held it in 16 quarters. The position peaked at $406K in Q2 2015. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Patten Group reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Patten Group sold 50 Gilead Sciences shares in Q1 2019, an estimated $3K.
  • Patten Group first reported a position in Gilead Sciences in Q4 2014 and held it in 16 quarters.
  • Patten Group's Gilead Sciences position peaked at $406K in Q2 2015.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Patten Group's 13F filing for Q1 2019, filed 14 May 2019.